Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian Gresham

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
JCO Precision Oncology|November 20, 2020
Dual Checkpoint Blockade in a Neuroendocrine Carcinoma With Dual PD-L1/PD-L2 Amplification and High Tumor Mutational BurdenJun Gong, Sandip Patel, Jacob J Adashek, et al.
Scientific Reports|July 2, 2025
A phase 1 safety and feasibility trial of a ketogenic diet plus standard of care for patients with recently diagnosed glioblastomaL J Amaral, Gillian Gresham, Sungjin Kim, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2023
Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 TrialVinicius F Calsavara, Norah L Henry, Ron D Hays, et al.
Methods and Protocols|May 23, 2023
The Streaming Web-Based Exercise at Home Study for Breast and Prostate Cancer Survivors: A Feasibility Study ProtocolCelina H Shirazipour, Rachel M Ruggieri-Bacani, Laura Lockshon, et al.
Scientific Reports|September 2, 2022
Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinomaJun Gong, Shant Thomassian, Sungjin Kim, et al.
Scientific Reports|November 5, 2022
Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinomaJun Gong, Shant Thomassian, Sungjin Kim, et al.
Cancer|October 22, 2025
Analyses of adverse events and patient-reported outcomes with the toxicity index in cancer clinical trialsGillian Gresham, N Lynn Henry, Hanna Bandos, et al.
Health & Place|April 26, 2026
Assessing physical activity barriers and facilitators among Latinos/as: Qualitative findings from a citizen science pilot study in a Los Angeles parkArjan S Walia, Zakaria N Doueiri, Vignesh Kumar, et al.
Journal of Cachexia, Sarcopenia and Muscle|October 5, 2021
Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient-reported outcomes in pancreatic cancer cachexiaGillian Gresham, Veronica R Placencio-Hickok, Marie Lauzon, et al.
International Journal of Epidemiology|October 10, 2015
Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomasZahra Montazeri, Evropi Theodoratou, Christine Nyiraneza, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
JCO Precision Oncology|November 20, 2020
Dual Checkpoint Blockade in a Neuroendocrine Carcinoma With Dual PD-L1/PD-L2 Amplification and High Tumor Mutational BurdenJun Gong, Sandip Patel, Jacob J Adashek, et al.
Scientific Reports|July 2, 2025
A phase 1 safety and feasibility trial of a ketogenic diet plus standard of care for patients with recently diagnosed glioblastomaL J Amaral, Gillian Gresham, Sungjin Kim, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2023
Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 TrialVinicius F Calsavara, Norah L Henry, Ron D Hays, et al.
Methods and Protocols|May 23, 2023
The Streaming Web-Based Exercise at Home Study for Breast and Prostate Cancer Survivors: A Feasibility Study ProtocolCelina H Shirazipour, Rachel M Ruggieri-Bacani, Laura Lockshon, et al.
Scientific Reports|September 2, 2022
Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinomaJun Gong, Shant Thomassian, Sungjin Kim, et al.
Scientific Reports|November 5, 2022
Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinomaJun Gong, Shant Thomassian, Sungjin Kim, et al.
Cancer|October 22, 2025
Analyses of adverse events and patient-reported outcomes with the toxicity index in cancer clinical trialsGillian Gresham, N Lynn Henry, Hanna Bandos, et al.
Health & Place|April 26, 2026
Assessing physical activity barriers and facilitators among Latinos/as: Qualitative findings from a citizen science pilot study in a Los Angeles parkArjan S Walia, Zakaria N Doueiri, Vignesh Kumar, et al.
Journal of Cachexia, Sarcopenia and Muscle|October 5, 2021
Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient-reported outcomes in pancreatic cancer cachexiaGillian Gresham, Veronica R Placencio-Hickok, Marie Lauzon, et al.
International Journal of Epidemiology|October 10, 2015
Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomasZahra Montazeri, Evropi Theodoratou, Christine Nyiraneza, et al.
Pageof 6